![]() |
Volumn 72, Issue 6, 2009, Pages 629-630
|
Evo-Devo and the evolution of cancer: A hypothesis for metamorphic therapies for the cancers of prolactin-influenced tumourigenesis: With special reference to glioblastoma multiforme (GBM)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DOPAMINE RECEPTOR STIMULATING AGENT;
HORMONE RECEPTOR BLOCKING AGENT;
PROLACTIN;
PROLACTIN RECEPTOR ANTAGONIST;
THYROXINE;
UNCLASSIFIED DRUG;
ARTICLE;
BREAST CANCER;
BREAST TUMOR;
CANCER RESEARCH;
CANCER STEM CELL;
CARCINOGENESIS;
COLORECTAL TUMOR;
EVOLUTION;
GLIOBLASTOMA;
METAMORPHOSIS;
ONTOGENY;
PRIORITY JOURNAL;
PROSTATE TUMOR;
ANIMALS;
ANTINEOPLASTIC AGENTS;
GLIOBLASTOMA;
HUMANS;
MODELS, BIOLOGICAL;
PROLACTIN;
AMPHIBIA;
EQUIDAE;
VERTEBRATA;
|
EID: 62949245191
PISSN: 03069877
EISSN: None
Source Type: Journal
DOI: 10.1016/j.mehy.2009.01.014 Document Type: Article |
Times cited : (2)
|
References (11)
|